3450 results for «02060+2025年11月股价»
3450 results
Advancing renal denervation in China: from guidelines to practice
20 May 2025 – From EuroPCR 2025
Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...
Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session offers a comprehensive update on cardiogenic shock and high-risk PCI, featuring expert analysis of the DanGer-SHOCK and ECLS-SHOCK trials, new insights one year after DanGer-SHOCK, and practical considerations for managing PCI in patients with severely reduced LVEF. Expect to gain a deeper...
From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management
20 May 2025 – From EuroPCR 2025
Watch this EuroPCR 2025 session on managing calcified coronary stenoses, featuring a recorded live case, two focused lectures, and expert faculty insights. Learn why intravascular ultrasound (IVUS) is essential for assessing lesion severity and morphology, discover how selecting the right calcium modification tools drives procedural success...
From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions
21 May 2025 – From EuroPCR 2025
Learn how 4D intracardiac echocardiography (ICE) is reshaping structural heart procedures. This EuroPCR 2025 session takes you through the latest in imaging technology—highlighting the benefits of 4D ICE and AI integration in improving the safety, precision, and efficiency of mitral and tricuspid interventions. From valve repair...
Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?
22 May 2025 – From EuroPCR 2025
Discover how the novel Hertz Contact Intravascular Lithotripsy (IVL) is pushing the boundaries of calcium modification in challenging coronary lesions.
This EuroPCR 2025 session shares real-world insights confirming the promising results of the PINNACLE I trial, with LithiX IVL proving safe and effective across eccentric, concentric, and...
Optimising self-expandable TAVI clinical outcomes without compromise
22 May 2025 – From EuroPCR 2025
Optimising patient outcomes in self-expandable TAVI starts with a clear plan for today, and tomorrow. This EuroPCR 2025 session explores how to make each step count, from access to implantation and closure, using a real-life case of a 77-year-old woman with severe symptomatic aortic stenosis and...
The new global era of patient care with CathWorks FFRangio
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights how CathWorks FFRangio is reshaping coronary physiology assessment worldwide. Through case-based experience and real-world data, it showcases the integration of FFRangio into routine clinical workflows—from early adoption at Clinique Pasteur in Toulouse to implementation across the UK. The session also presents...
Treating complex CAD indications with sirolimus coated balloon: evidence and performance
22 May 2025 – From EuroPCR 2025
Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...
Innovations in TMVR and Intrepid trial updates
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...
Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...
Mastering techniques from basic to complex - Mitral regurgitation diagnosis and suitability for TEER
07 Feb 2025 – From PCR Tokyo Valves 2025
Watch this PCR Tokyo Valves 2025 session, where leading experts dive into the latest advancements in mitral valve treatment, to explore how to assess mitral regurgitation using TEE and CT to determine suitability for Transcatheter Edge-to-Edge Repair (TEER), and discover key clinical scenarios where TEER may...
Mastering techniques from basic to complex - TEER for functional mitral regurgitation
07 Feb 2025 – From PCR Tokyo Valves 2025
Explore the complexities of functional mitral regurgitation (FMR) in this PCR Tokyo Valves 2025 session, where experts delve into key anatomical challenges and advanced TEER techniques. Learn why surgery remains the first-line treatment for atrial FMR, particularly when concomitant tricuspid regurgitation is present, and when radiofrequency...
M-TEER for primary mitral regurgitation
08 Feb 2025 – From PCR Tokyo Valves 2025
In this PCR Tokyo Valves 2025 session on M-TEER for primary mitral regurgitation, gain valuable insights starting with an overview of current TEER devices. Benefit from four case studies that highlight the features of these devices, explore strategies to prevent mitral regurgitation recurrence post-TEER, and delve...
Late-Breaking Trial session
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...
Align for the future with next gen Myval transcatheter heart valve series
16 Nov 2025 – From PCR London Valves 2025
Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...
Meet with Myval THV series with real-world case-based learning
17 Nov 2025 – From PCR London Valves 2025
Discover the latest insights from the Myval THV series in this session from PCR London Valves 2025. Through real-world, case-based learning, the session explores lifetime management strategies for TAVI patients, the clinical relevance of intermediate and extra-large valve sizing, and the impact of foreshortening on accurate...
A simple low profile solution to the pulmonary embolism problem: EKOS
21 May 2025 – From EuroPCR 2025
Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...
Advanced imaging in structural heart disease interventions
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.
You'll also discover how AI-enabled device detection technology is being integrated into...
Align for the future with the Myval Octapro transcatheter heart valve series
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.
Clinical insights are backed by key data...
Broadening OPTIONs for LAA closure: innovations and outcomes
20 May 2025 – From EuroPCR 2025
Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...
